Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683)
Conditions: Rhinitis, Allergic, Seasonal; Rhinitis, Allergic, PerennialInterventions: Drug: 5-mg Desloratadine; Drug: PlaceboSponsor: Merck Sharp & Dohme Corp.Completed - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2006 Category: Research Source Type: clinical trials